Researchers have identified a drug candidate which appears to suppress a critical genetic alteration in dysfunctional cells.
in a mouse model of Rett syndrome, researchers were able to reverse abnormalities in brain activity and improve neurological function by treating animals with an FDA-approved anesthesia drug, ketamine.
